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Abstract
Objectives: Actinidic archaea have been related to the 
pathogenesis of schizophrenia, malignancy, metabolic 
syndrome x,  autoimmune disease and neuronal 
degeneration. An actinide dependent shadow biosphere of 
archaea and viroids in the above mentioned disease states 
is described. Actinidic archaea have a mevalonate pathway 
and are cholesterol catabolizing. They can use cholesterol 
as a carbon and energy source. Archaeal cholesterol 
catabolism can generate porphyrins via the cholesterol 
ring oxidase generated pyruvate and GABA shunt 
pathway. Archaea can produce a secondary porphyria by 
inducing the enzyme heme oxygenase resulting in heme 
depletion and activation of the enzyme ALA synthase. 
Porphyrins have been related to schizophrenia, metabolic 
syndrome x, malignancy, systemic lupus erythematosis, 
multiple sclerosis and Alzheimer’s diseases. The role 
of archaeal porphyrins in regulation of cell functions 
and neuroimmunoendocrine integration is discussed. 
Porphyrins are prebiotic molecules which are involved in 
abiogenesis and origin of life.
Methodology: Plasma from fasting heparinised 
blood was used and the experimental protocol was as 
follows (I) Plasma+phosphate buffered saline, (II) same 
as I+cholesterol substrate, (III) same as II+rutile 0.1 mg/
ml, (IV) same as II+ciprofl oxacine and doxycycline each 
in a concentration of 1 mg/ml. The following estimations 
were carried out: Cytochrome F420, free RNA, free DNA, 
polycyclic aromatic hydrocarbon, hydrogen peroxide, 
pyruvate, ammonia, glutamate, succinate, glycine, delta 
aminolevulinic acid and digoxin. The study also involved 
estimating the following parameters in the patient 
population- Hexokinase, porphyrins, pyruvate, glutamate, 
ammonia, succinic acid, serine, glycine, HMG CoA 
reductase, cytochrome C, blood ATP and heme oxygenase.
Results: Plasma of control subjects showed increased 
levels of the above mentioned parameters with after 
incubation for 1 hour and addition of cholesterol 
substrate resulted in still further significant increase in 
these parameters. The plasma of patients showed similar 
results but the extent of increase was more. The addition 
of antibiotics to the control plasma caused a decrease 
in all the parameters while addition of rutile increased 
their levels. The addition of antibiotics and rutile to the 
patient’s plasma produced the same changes but the 
extent of change was more in patient’s sera as compared 
to controls. There was upregulated archaeal porphyrin 
synthesis in the patient population which was archaeal in 
origin as indicated by actinide catalysis of the reactions. 
The cholesterol oxidase pathway generated pyruvate 
which entered the GABA shunt pathway. This resulted in 
synthesis of succinate and glycine which are substrates 
for ALA synthase. The study showed the patient’s blood 
had increased heme oxygenase activity, increased serine, 
glycine, succinic acid and porphyrins. The hexokinase 
activity was high. The pyruvate, glutamate, ammonia, 
GABA and succinic acid levels were elevated indicating 
blockade of PDH activity, and operation of the GABA 
shunt pathway. The cytoC levels were increased in the 
serum indicating mitochondrial dysfunction suggested 
by low blood ATP levels. This was indicative of the 
Warburg’s phenotype. The HMG CoA reductase activity 
was high indicating cholesterol synthesis.The RHCD 
population had values similar to the patient population. 
The LHCD population had opposite values. 
Conclusion: An actinide dependent shadow biosphere 
of archaea and viroids in the above mentioned disease 
states is described. The archaeal porphyrins can contribute 
to the pathgenesis of metabolic syndrome x, malignancy, 
psychiatric disorders, autoimmune disease, AIDS, prion 
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disease, neuronal degeneration and epileptogenesis. 
Archaeal porphyrin synthesis is crucial in the pathogenesis 
of these disorders. Porphyrins may serve as regulatory 
molecules modulating immune, neural, endocrine, 
metabolic and genetic systems. The porphyrins photo-
oxidation generated free radicals can produce immune 
activation, produce cell death, activate cell proliferation, 
produce insulin resistance and modulate conscious/
quantal perception. Porphyrins can regulate hemispheric 
dominance. The archaeal porphyrins functions as key 
regulatory molecules with mitochondrial benzodiazepine 
receptors playing an important role. The role of porphyrins 
in abiogenesis and origin of life as well as biological 
universe is discussed.
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INTRODUCTION
Actinidic archaea have been related to the pathogenesis of 
schizophrenia, malignancy, metabolic syndrome x, auto-
immune disease and neuronal degeneration. An actinide 
dependent shadow biosphere of archaea and viroids in the 
above mentioned disease states are described. Actinidic 
archaea have a mevalonate pathway and are cholesterol 
catabolizing[1-5]. They can use cholesterol as a carbon and 
energy source. Archaeal cholesterol catabolism can gener-
ate porphyrins via the cholesterol ring oxidase generated 
pyruvate and GABA shunt pathway. Archaea can produce 
a secondary porphyria by inducing the enzyme heme 
oxygenase resulting in heme depletion and activation of 
the enzyme ALA synthase. Porphyrins have been related 
to schizophrenia, metabolic syndrome x, malignancy, 
systemic lupus erythematosis, multiple sclerosis and Al-
zheimer’s diseases. The role of archaeal porphyrins in 
regulation of cell functions and neuroimmunoendocrine 
integration is discussed. Porphyrins are prebiotic mol-
ecules which are involved in abiogenesis and origin of 
life[1-5].
MATERIALS AND METHODS
The following groups were included in the study: 
endomyocardial fibrosis, alzheimer’s disease, multiple 
sclerosis, non-hodgkin’s lymphoma, metabolic syndrome 
x with cerebrovascular thrombosis and coronary 
artery disease, schizophrenia, autism, seizure disorder, 
creutzfeldt jakob disease and acquired immunodefi ciency 
syndrome. There were 10 patients in each group and 
each patient had an age and sex matched healthy control 
selected randomly from the general population. The 
blood samples were drawn in the fasting state before 
treatment was initiated. Plasma from fasting heparinised 
blood was used and the experimental protocol was as 
follows (I) Plasma+phosphate buffered saline, (II) same 
as I+cholesterol substrate, (III) same as II+rutile 0.1 mg/
ml, (IV) same as II+ciprofl oxacine and doxycycline each 
in a concentration of 1 mg/ml. Cholesterol substrate 
was prepared as described by Richmond. Aliquots were 
withdrawn at zero time immediately after mixing and after 
incubation at 37oC for 1 hour. The following estimations 
were carried out: Cytochrome F420, free RNA, free DNA, 
polycyclic aromatic hydrocarbon, hydrogen peroxide, 
pyruvate, ammonia, glutamate, delta aminolevulinic acid, 
succinate, glycine and digoxin. Cytochrome F420 was 
estimated fl ourimetrically (excitation wavelength 420 nm 
and emission wavelength 520 nm). Polycyclic aromatic 
hydrocarbon was estimated by measuring hydrogen 
peroxide liberated by using glucose reagent. The study 
also involved estimating the following parameters in 
the patient population- digoxin, bile acid, hexokinase, 
porphyrins, pyruvate, glutamate, ammonia, acetyl CoA, 
acetyl choline, HMG CoA reductase, cytochrome C, blood 
ATP, ATP synthase, ERV RNA (endogenous retroviral 
RNA), H2O2 (hydrogen peroxide), NOX (NADPH 
oxidase), TNF alpha and heme oxygenase[6-9]. Informed 
consent of the subjects and the approval of the ethics 
committee were obtained for the study. The statistical 
analysis was done by ANOVA. 
RESULTS
Plasma of control subjects showed increased levels of 
the above mentioned parameters with after incubation for 
1 hour and addition of cholesterol substrate resulted in 
still further signifi cant increase in these parameters. The 
plasma of patients showed similar results but the extent 
of increase was more. The addition of antibiotics to the 
control plasma caused a decrease in all the parameters 
while addition of rutile increased their levels. The addition 
of antibiotics to the patient’s plasma caused a decrease 
in all the parameters while addition of rutile increased 
their levels but the extent of change was more in patient’s 
sera as compared to controls. The results are expressed 
in tables 1-6 as percentage change in the parameters 
after 1 hour incubation as compared to the values at 
zero time. There was upregulated archaeal porphyrin 
synthesis in the patient population which was archaeal in 
origin as indicated by actinide catalysis of the reactions. 
The cholesterol oxidase pathway generated pyruvate 
which entered the GABA shunt pathway. This resulted in 
synthesis of succinate and glycine which are substrates for 
ALA synthase. 
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The study showed the patient’s blood and right hemi-
spheric dominance had increased heme oxygenase activity 
and porphyrins. The hexokinase activity was high. The 
pyruvate, glutamate and ammonia levels were elevated 
indicating blockade of PDH activity, and operation of 
the GABA shunt pathway. The acetyl CoA levels were 
low and acetyl choline was decreased. The cytoC levels 
were increased in the serum indicating mitochondrial 
dysfunction suggested by low blood ATP levels. This 
was indicative of the Warburg’s phenotype. There was 
increased NOX and TNF alpha levels indicating immune 
activation. The HMG CoA reductase activity was high 
indicating cholesterol synthesis. The bile acid levels were 
low indicating depletion of cytochrome P450. The normal 
population with right hemispheric dominance had values 
resembling the patient population with increased porphy-
rin synthesis. The normal population with left hemispheric 
dominance had low values with decreased porphyrin syn-
thesis. 
Experimental Study
Table 1
Effect of Rutile and Antibiotics on Cytochrome F420 and PAH
Group
CYT F420 %
(Increase with Rutile)
CYT F420 %
(Decrease with Doxy+Cipro)
PAH % change
(Increase with Rutile)
PAH % change
(Decrease with Doxy+Cipro)
Mean + SD Mean + SD Mean + SD Mean + SD
Normal 4.48 0.15 18.24 0.66 4.45 0.14 18.25 0.72
Schizo 23.24 2.01 58.72 7.08 23.01 1.69 59.49 4.30
Seizure 23.46 1.87 59.27 8.86 22.67 2.29 57.69 5.29
AD 23.12 2.00 56.90 6.94 23.26 1.53 60.91 7.59
MS 22.12 1.81 61.33 9.82 22.83 1.78 59.84 7.62
NHL 22.79 2.13 55.90 7.29 22.84 1.42 66.07 3.78
DM 22.59 1.86 57.05 8.45 23.40 1.55 65.77 5.27
AIDS 22.29 1.66 59.02 7.50 23.23 1.97 65.89 5.05
CJD 22.06 1.61 57.81 6.04 23.46 1.91 61.56 4.61
Autism 21.68 1.90 57.93 9.64 22.61 1.42 64.48 6.90
EMF 22.70 1.87 60.46 8.06 23.73 1.38 65.20 6.20
F value 306.749
P value < 0.001
F value 130.054
P value < 0.001
F value 391.318
P value < 0.001
F value 257.996
P value < 0.001
Table 2
Effect of Rutile and Antibiotics on Free RNA and DNA 
Group
DNA % change
(Increase with Rutile)
DNA % change
(Decrease with Doxy+Cipro)
RNA % change
(Increase with Rutile)
RNA % change
(Decrease with Doxy+Cipro)
Mean + SD Mean + SD Mean + SD Mean + SD
Normal 4.37 0.15 18.39 0.38 4.37 0.13 18.38 0.48
Schizo 23.28 1.70 61.41 3.36 23.59 1.83 65.69 3.94
Seizure 23.40 1.51 63.68 4.66 23.08 1.87 65.09 3.48
AD 23.52 1.65 64.15 4.60 23.29 1.92 65.39 3.95
MS 22.62 1.38 63.82 5.53 23.29 1.98 67.46 3.96
NHL 22.42 1.99 61.14 3.47 23.78 1.20 66.90 4.10
DM 23.01 1.67 65.35 3.56 23.33 1.86 66.46 3.65
AIDS 22.56 2.46 62.70 4.53 23.32 1.74 65.67 4.16
CJD 23.30 1.42 65.07 4.95 23.11 1.52 66.68 3.97
Autism 22.12 2.44 63.69 5.14 23.33 1.35 66.83 3.27
EMF 22.29 2.05 58.70 7.34 22.29 2.05 67.03 5.97
F value 337.577
P value < 0.001
F value 356.621
P value < 0.001
F value 427.828
P value < 0.001
F value 654.453
P value < 0.001
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Table 3
Effect of Rutile and Antibiotics on Digoxin and Delta Aminolevulinic Acid
Group
Digoxin (ng/ml)
(Increase with Rutile)
Digoxin (ng/ml)
(Decrease with Doxy+Cipro)
ALA %
(Increase with Rutile)
ALA %
(Decrease with Doxy+Cipro)
Mean + SD Mean + SD Mean + SD Mean + SD
Normal 0.11 0.00 0.054 0.003 4.40 0.10 18.48 0.39
Schizo 0.55 0.06 0.219 0.043 22.52 1.90 66.39 4.20
Seizure 0.51 0.05 0.199 0.027 22.83 1.90 67.23 3.45
AD 0.55 0.03 0.192 0.040 23.67 1.68 66.50 3.58
MS 0.52 0.03 0.214 0.032 22.38 1.79 67.10 3.82
NHL 0.54 0.04 0.210 0.042 23.34 1.75 66.80 3.43
DM 0.47 0.04 0.202 0.025 22.87 1.84 66.31 3.68
AIDS 0.56 0.05 0.220 0.052 23.45 1.79 66.32 3.63
CJD 0.53 0.06 0.212 0.045 23.17 1.88 68.53 2.65
Autism 0.53 0.08 0.205 0.041 23.20 1.57 66.65 4.26
EMF 0.51 0.05 0.213 0.033 22.29 2.05 61.91 7.56
F value 135.116
P value < 0.001
F value 71.706
P value < 0.001
F value 372.716
P value < 0.001
F value 556.411
P value < 0.001
Table 4
Effect of Rutile and Antibiotics on Succinate and Glycine
 Group
Succinate %
(Increase with Rutile)
Succinate %
(Decrease with Doxy+Cipro)
Glycine % change
(Increase with Rutile)
Glycine % change
(Decrease with Doxy+Cipro)
Mean + SD Mean + SD Mean + SD Mean + SD
Normal 4.41 0.15 18.63 0.12 4.34 0.15 18.24 0.37
Schizo 22.76 2.20 67.63 3.52 22.79 2.20 64.26 6.02
Seizure 22.28 1.52 64.05 2.79 22.82 1.56 64.61 4.95
AD 23.81 1.90 66.95 3.67 23.12 1.71 65.12 5.58
MS 24.10 1.61 65.78 4.43 22.73 2.46 65.87 4.35
NHL 23.43 1.57 66.30 3.57 22.98 1.50 65.13 4.87
DM 23.70 1.75 68.06 3.52 23.81 1.49 64.89 6.01
AIDS 23.66 1.67 65.97 3.36 23.09 1.81 65.86 4.27
CJD 22.92 2.14 67.54 3.65 21.93 2.29 63.70 5.63
Autism 21.88 1.19 66.28 3.60 23.02 1.65 67.61 2.77
EMF 22.29 1.33 65.38 3.62 22.13 2.14 66.26 3.93
F value 403.394
P value < 0.001
F value 680.284
P value < 0.001
F value 348.867
P value < 0.001
F value 364.999
P value < 0.001
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Table 5
Effect of Rutile and Antibiotics on Pyruvate and Glutamate
Group
Pyruvate % change
(Increase with Rutile)
Pyruvate % change
(Decrease with Doxy+Cipro)
Glutamate
(Increase with Rutile)
Glutamate
 (Decrease with Doxy+Cipro)
Mean + SD Mean + SD Mean + SD Mean + SD
Normal 4.34 0.21 18.43 0.82 4.21 0.16 18.56 0.76
Schizo 20.99 1.46 61.23 9.73 23.01 2.61 65.87 5.27
Seizure 20.94 1.54 62.76 8.52 23.33 1.79 62.50 5.56
AD 22.63 0.88 56.40 8.59 22.96 2.12 65.11 5.91
MS 21.59 1.23 60.28 9.22 22.81 1.91 63.47 5.81
NHL 21.19 1.61 58.57 7.47 22.53 2.41 64.29 5.44
DM 20.67 1.38 58.75 8.12 23.23 1.88 65.11 5.14
AIDS 21.21 2.36 58.73 8.10 21.11 2.25 64.20 5.38
CJD 21.07 1.79 63.90 7.13 22.47 2.17 65.97 4.62
Autism 21.91 1.71 58.45 6.66 22.88 1.87 65.45 5.08
EMF 22.29 2.05 62.37 5.05 21.66 1.94 67.03 5.97
F value 321.255
P value < 0.001
F value 115.242
P value < 0.001
F value 292.065
P value < 0.001
F value 317.966
P value < 0.001
Table 6
Effect of Rutile and Antibiotics on Hydrogen Peroxide and Ammonia
Group
H2O2 %
(Increase with Rutile)
H2O2 %
(Decrease with Doxy+Cipro)
Ammonia %
(Increase with Rutile)
Ammonia %
(Decrease with Doxy+Cipro)
Mean + SD Mean + SD Mean + SD Mean + SD
Normal 4.43 0.19 18.13 0.63 4.40 0.10 18.48 0.39
Schizo 22.50 1.66 60.21 7.42 22.52 1.90 66.39 4.20
Seizure 23.81 1.19 61.08 7.38 22.83 1.90 67.23 3.45
AD 22.65 2.48 60.19 6.98 23.67 1.68 66.50 3.58
MS 21.14 1.20 60.53 4.70 22.38 1.79 67.10 3.82
NHL 23.35 1.76 59.17 3.33 23.34 1.75 66.80 3.43
DM 23.27 1.53 58.91 6.09 22.87 1.84 66.31 3.68
AIDS 23.32 1.71 63.15 7.62 23.45 1.79 66.32 3.63
CJD 22.86 1.91 63.66 6.88 23.17 1.88 68.53 2.65
Autism 23.52 1.49 63.24 7.36 23.20 1.57 66.65 4.26
EMF 23.29 1.67 60.52 5.38 22.29 2.05 61.91 7.56
F value 380.721
P value < 0.001
F value 171.228
P value < 0.001
F value 372.716
P value < 0.001
F value 556.411
P value < 0.001
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Section 2: Patient Study
Table 1
RBC Dig (ng/ml RBC Susp)
Group Mean + SD
NO/BHCD 0.58 0.07
RHCD 1.41 0.23
LHCD 0.18 0.05
Schizo 1.38 0.26
Seizure 1.23 0.26
HD 1.34 0.31
AD 1.10 0.08
MS 1.21 0.21
SLE 1.50 0.33
NHL 1.26 0.23
Glio 1.27 0.24
DM 1.35 0.26
CAD 1.22 0.16
CVA 1.33 0.27
AIDS 1.31 0.24
CJD 1.48 0.27
Autism 1.19 0.24
DS 1.34 0.25
Cerbral Palsy 1.44 0.19
CRF 1.26 0.26
Cirr/Hep Fail 1.50 0.20
Muc Angio 1.40 0.32
EMF 1.51 0.29
CCP 1.35 0.22
Exposure to EMF 1.41 0.30
F value 60.288
P value < 0.001
Table 2
Cytochrome F 420
Group Mean + SD
NO/BHCD 1.00 0.00
RHCD 4.00 0.00
LHCD 0.00 0.00
Schizo 4.00 0.00
Seizure 4.00 0.00
HD 4.00 0.00
AD 4.00 0.00
MS 4.00 0.00
SLE 4.00 0.00
NHL 4.00 0.00
Glio 4.00 0.00
DM 4.00 0.00
Group Mean + SD
CAD 4.00 0.00
CVA 4.00 0.00
AIDS 4.00 0.00
CJD 4.00 0.00
Autism 4.00 0.00
DS 4.00 0.00
Cerbral Palsy 4.00 0.00
CRF 4.00 0.00
Cirr/Hep Fail 4.00 0.00
Muc Angio 4.00 0.00
EMF 4.00 0.00
CCP 4.00 0.00
Exposure to EMF 4.00 0.00
F value 0.001
P value < 0.001
Table 3
ERV RNA (ug/ml)
Group Mean + SD
NO/BHCD 17.75 0.72
RHCD 55.17 5.85
LHCD 8.70 0.90
Schizo 51.17 3.65
Seizure 50.04 3.91
HD 51.16 7.78
AD 51.56 3.69
MS 47.90 6.99
SLE 48.20 5.53
NHL 51.08 5.24
Glio 51.57 2.66
DM 51.98 5.05
CAD 50.00 5.91
CVA 51.06 4.83
AIDS 50.15 6.96
CJD 49.85 6.40
Autism 52.87 7.04
DS-50 47.28 3.55
Cerbral Palsy 53.49 4.15
CRF 49.39 5.51
Cirr/Hep Fail 46.82 4.73
Muc Angio 46.37 4.87
EMF 47.47 4.34
CCP 48.54 5.97
Exposure to EMF 51.01 4.77
F value 194.418
P value < 0.001To be continued
Continued
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Table 4
H2O2 (umol/ml RBC)
Group Mean + SD
NO/BHCD 177.43 6.71
RHCD 278.29 7.74
LHCD 111.63 5.40
Schizo 274.88 8.73
Seizure 278.90 11.20
HD 295.37 3.78
AD 277.47 10.90
MS 280.89 11.25
SLE 278.59 11.51
NHL 283.39 10.67
Glio 278.19 12.80
DM 280.89 10.58
CAD 280.89 13.79
CVA 287.33 9.47
AIDS 278.58 12.72
CJD 286.16 10.90
Autism 274.52 9.29
DS-50 283.04 9.17
Cerbral Palsy 273.70 12.37
CRF 285.51 8.79
Cirr/Hep Fail 275.97 10.66
Muc Angio 290.37 9.10
EMF 287.49 9.81
CCP 277.50 7.51
Exposure to EMF 276.49 10.92
F value 713.569
P value < 0.001
Table 5
NOx (OD diff/hr/mgpro)
Group Mean + SD
NO/BHCD 0.012 0.001
RHCD 0.036 0.008
LHCD 0.007 0.001
Schizo 0.036 0.009
Seizure 0.038 0.007
HD 0.035 0.011
AD 0.036 0.007
MS 0.034 0.009
SLE 0.038 0.008
NHL 0.041 0.006
Glio 0.038 0.007
DM 0.041 0.005
CAD 0.038 0.009
Group Mean + SD
CVA 0.037 0.007
AIDS 0.039 0.010
CJD 0.039 0.006
Autism 0.036 0.006
DS-50 0.035 0.009
Cerbral Palsy 0.038 0.008
CRF 0.039 0.008
Cirr/Hep Fail 0.037 0.010
Muc Angio 0.039 0.010
EMF 0.035 0.008
CCP 0.040 0.006
Exposure to EMF 0.038 0.007
F value 44.896
P value < 0.001
Table 6
TNF ALP (pg/ml)
Group Mean + SD
NO/BHCD 17.94 0.59
RHCD 78.63 5.08
LHCD 9.29 0.81
Schizo 78.23 7.13
Seizure 79.28 4.55
HD 82.13 3.97
AD 79.65 5.57
MS 80.18 5.67
SLE 81.03 6.22
NHL 77.98 5.68
Glio 79.18 5.88
DM 78.36 6.68
CAD 78.15 3.72
CVA 77.59 5.24
AIDS 79.17 5.88
CJD 80.41 5.70
Autism 76.71 5.25
DS-50 80.30 6.65
Cerbral Palsy 80.02 6.82
CRF 81.36 5.37
Cirr/Hep Fail 77.61 4.42
Muc Angio 79.38 5.14
EMF 80.04 4.69
CCP 80.34 4.73
Exposure to EMF 76.41 5.96
F value 427.654
P value < 0.001
To be continued
Continued
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Table 7
ALA (umol24)
Group Mean + SD
NO/BHCD 15.44 0.50
RHCD 63.50 6.95
LHCD 3.86 0.26
Schizo 66.16 6.51
Seizure 68.28 6.02
HD 67.30 5.98
AD 67.32 5.40
MS 64.00 7.33
SLE 65.01 5.42
NHL 63.21 6.55
Glio 67.67 5.69
DM 64.72 6.81
CAD 66.66 7.77
CVA 69.02 4.86
AIDS 67.78 4.41
CJD 66.99 3.71
Autism 68.16 4.92
DS-50 64.99 6.72
Cerbral Palsy 65.56 6.28
CRF 67.61 5.55
Cirr/Hep Fail 66.28 6.55
Muc Angio 67.86 5.65
EMF 64.76 5.23
CCP 66.68 4.14
Exposure to EMF 68.41 5.53
F value 295.467
P value < 0.001
Table 8
PBG (umol24)
Group Mean + SD
NO/BHCD 20.82 1.19
RHCD 42.20 8.50
LHCD 12.11 1.34
Schizo 42.50 3.23
Seizure 46.54 4.55
HD 47.25 4.19
AD 49.83 3.45
MS 46.85 3.49
SLE 48.55 3.81
NHL 47.17 4.86
Glio 46.84 4.43
DM 48.15 3.36
CAD 47.00 3.81
Group Mean + SD
CVA 46.33 4.01
AIDS 48.03 3.64
CJD 47.94 5.33
Autism 42.04 2.38
DS-50 45.69 4.18
Cerbral Palsy 44.58 4.52
CRF 46.81 4.62
Cirr/Hep Fail 48.23 2.36
Muc Angio 44.08 2.81
EMF 44.82 3.46
CCP 48.70 3.35
Exposure to EMF 47.27 3.42
F value 183.296
P value < 0.001
Table 9
URO (nmol24)
Group Mean + SD
NO/BHCD 50.18 3.54
RHCD 250.28 23.43
LHCD 9.51 1.19
Schizo 267.81 64.05
Seizure 290.44 57.65
HD 286.84 24.18
AD 259.61 33.18
MS 277.36 15.48
SLE 294.51 58.62
NHL 310.25 40.44
Glio 304.19 14.16
DM 285.46 29.46
CAD 314.01 17.82
CVA 320.85 24.73
AIDS 306.61 22.47
CJD 317.92 29.63
Autism 318.84 82.90
DS-50 258.33 37.85
Cerbral Palsy 280.16 26.14
CRF 301.78 48.22
Cirr/Hep Fail 276.51 16.66
Muc Angio 303.86 13.91
EMF 300.90 31.96
CCP 287.09 15.63
Exposure to EMF 288.21 26.17
F value 160.533
P value < 0.001
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Table 10
COPRO (nmol/24)
Group Mean + SD
NO/BHCD 137.94 4.75
RHCD 389.01 54.11
LHCD 64.33 13.09
Schizo 401.49 50.73
Seizure 436.71 52.95
HD 432.22 50.11
AD 433.17 45.61
MS 440.35 25.34
SLE 447.39 39.84
NHL 495.98 39.11
Glio 479.35 58.86
DM 422.27 33.86
CAD 426.14 24.28
CVA 402.16 33.80
AIDS 429.72 24.97
CJD 429.24 18.29
Autism 423.29 47.57
DS-50 421.52 36.57
Cerbral Palsy 431.39 28.88
CRF 427.57 33.55
Cirr/Hep Fail 436.44 25.65
Muc Angio 441.58 25.51
EMF 443.22 38.14
CCP 442.85 49.61
Exposure to EMF 444.94 38.89
F value 279.759
P value < 0.001
Table 11
PROTO (Ab unit)
Group Mean + SD
NO/BHCD 10.35 0.38
RHCD 42.46 6.36
LHCD 2.64 0.42
Schizo 44.30 2.66
Seizure 49.59 1.70
HD 49.36 4.18
AD 49.68 3.30
MS 50.81 3.21
SLE 52.94 3.67
NHL 54.80 4.04
Glio 53.73 5.34
DM 49.80 4.01
CAD 49.51 2.27
Group Mean + SD
CVA 46.74 4.28
AIDS 49.32 5.13
CJD 50.02 4.58
Autism 47.50 2.87
DS-50 50.97 7.07
Cerbral Palsy 49.23 3.91
CRF 49.66 4.41
Cirr/Hep Fail 50.56 1.63
Muc Angio 47.86 3.34
EMF 51.37 4.86
CCP 50.36 3.49
Exposure to EMF 50.59 1.71
F value 424.198
P value < 0.001
Table 12
HEME (uM)
Group Mean + SD
NO/BHCD 30.27 0.81
RHCD 12.47 2.82
LHCD 50.55 1.07
Schizo 12.82 2.40
Seizure 13.03 0.70
HD 11.81 0.80
AD 12.09 1.12
MS 11.87 1.84
SLE 12.95 1.53
NHL 11.76 1.37
Glio 13.68 1.67
DM 12.83 2.07
CAD 11.39 1.10
CVA 11.26 0.95
AIDS 11.60 1.23
CJD 11.76 1.32
Autism 12.37 2.09
DS-50 11.81 1.14
Cerbral Palsy 11.61 1.36
CRF 12.03 1.40
Cirr/Hep Fail 11.92 1.33
Muc Angio 12.13 1.10
EMF 12.61 2.00
CCP 12.01 1.53
Exposure to EMF 12.36 1.26
F value 1472.05
P value < 0.001To be continued
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Table 13
Bilirubin (mg/dl)
Group Mean + SD
NO/BHCD 0.55 0.02
RHCD 1.70 0.20
LHCD 0.21 0.00
Schizo 1.74 0.08
Seizure 1.84 0.07
HD 1.83 0.09
AD 1.77 0.13
MS 1.81 0.10
SLE 1.82 0.08
NHL 1.84 0.08
Glio 1.76 0.11
DM 1.77 0.19
CAD 1.75 0.12
CVA 1.82 0.10
AIDS 1.79 0.08
CJD 1.82 0.09
Autism 1.83 0.16
DS-50 1.85 0.07
Cerbral Palsy 1.85 0.09
CRF 1.76 0.22
Cirr/Hep Fail 1.81 0.10
Muc Angio 1.78 0.24
EMF 1.79 0.07
CCP 1.84 0.07
Exposure to EMF 1.75 0.22
F value 370.517
P value < 0.001
Table 14
Biliverdin (Ab unit)
Group Mean + SD
NO/BHCD 0.030 0.001
RHCD 0.067 0.011
LHCD 0.017 0.001
Schizo 0.073 0.013
Seizure 0.070 0.015
HD 0.071 0.014
AD 0.073 0.016
MS 0.079 0.007
SLE 0.061 0.006
NHL 0.077 0.011
Glio 0.073 0.012
DM 0.067 0.014
CAD 0.080 0.007
Group Mean + SD
CVA 0.079 0.009
AIDS 0.072 0.013
CJD 0.066 0.009
Autism 0.072 0.014
DS-50 0.071 0.015
Cerbral Palsy 0.069 0.012
CRF 0.070 0.012
Cirr/Hep Fail 0.076 0.009
Muc Angio 0.067 0.014
EMF 0.074 0.009
CCP 0.073 0.011
Exposure to EMF 0.073 0.013
F value 59.963
P value < 0.001
Table 15
ATP Synth (umol/gHb)
Group Mean + SD
NO/BHCD 0.36 0.13
RHCD 2.73 0.94
LHCD 0.09 0.01
Schizo 2.66 0.58
Seizure 3.09 0.65
HD 3.34 0.84
AD 3.34 0.75
MS 3.05 0.52
SLE 2.85 0.34
NHL 3.01 0.55
Glio 2.70 0.62
DM 3.19 0.89
CAD 2.99 0.65
CVA 2.98 0.78
AIDS 3.29 0.63
CJD 3.21 0.95
Autism 2.67 0.80
DS-50 3.15 0.73
Cerbral Palsy 3.14 0.46
CRF 3.14 0.57
Cirr/Hep Fail 3.01 0.47
Muc Angio 2.92 0.55
EMF 3.12 0.60
CCP 3.15 0.46
Exposure to EMF 3.39 1.03
F value 54.754
P value < 0.001
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Table 16
SE ATP (umol/dl)
Group Mean + SD
NO/BHCD 0.42 0.11
RHCD 2.24 0.44
LHCD 0.02 0.01
Schizo 1.26 0.19
Seizure 1.66 0.56
HD 1.27 0.26
AD 2.06 0.19
MS 1.63 0.26
SLE 1.59 0.22
NHL 1.73 0.26
Glio 1.48 0.32
DM 1.97 0.11
CAD 1.57 0.37
CVA 1.49 0.27
AIDS 1.59 0.38
CJD 1.69 0.43
Autism 2.03 0.12
DS-50 1.17 0.11
Cerbral Palsy 1.56 0.39
CRF 1.53 0.33
Cirr/Hep Fail 1.32 0.26
Muc Angio 1.35 0.29
EMF 1.56 0.48
CCP 1.51 0.38
Exposure to EMF 1.37 0.27
F value 67.588
P value < 0.001
Table 17
Cyto C (ng/ml)
Group Mean + SD
NO/BHCD 2.79 0.28
RHCD 12.39 1.23
LHCD 1.21 0.38
Schizo 11.58 0.90
Seizure 12.06 1.09
HD 12.65 1.06
AD 11.94 0.86
MS 11.81 0.67
SLE 11.73 0.56
NHL 11.91 0.49
Glio 13.00 0.42
DM 12.95 0.56
CAD 11.51 0.47
Group Mean + SD
CVA 12.74 0.80
AIDS 12.29 0.89
CJD 12.19 1.22
Autism 12.48 0.79
DS-50 12.79 1.15
Cerbral Palsy 12.14 1.30
CRF 12.66 1.01
Cirr/Hep Fail 12.81 0.90
Muc Angio 12.84 0.74
EMF 12.72 0.92
CCP 12.23 0.94
Exposure to EMF 12.26 1.00
F value 445.772
P value < 0.001
Table 18
Lact (mg/dl)
Group Mean + SD
NO/BHCD 7.38 0.31
RHCD 25.99 8.10
LHCD 2.75 0.41
Schizo 22.07 1.06
Seizure 21.78 0.58
HD 24.28 1.69
AD 22.04 0.64
MS 23.32 1.10
SLE 23.06 1.49
NHL 22.83 1.24
Glio 22.20 0.85
DM 25.56 7.93
CAD 22.83 0.82
CVA 23.03 1.26
AIDS 24.87 4.14
CJD 23.02 1.61
Autism 21.95 0.65
DS-50 23.69 2.19
Cerbral Palsy 23.12 1.81
CRF 23.42 1.20
Cirr/Hep Fail 26.20 5.29
Muc Angio 23.64 1.43
EMF 25.35 5.52
CCP 23.66 1.64
Exposure to EMF 23.31 1.46
F value 162.945
P value < 0.001To be continued
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Table 19
Pyru (umol/l)
Group Mean + SD
NO/BHCD 40.51 1.42
RHCD 100.51 12.32
LHCD 23.79 2.51
Schizo 96.54 9.96
Seizure 90.46 8.30
HD 95.44 12.04
AD 97.26 8.26
MS 102.48 13.20
SLE 100.51 9.79
NHL 95.81 12.18
Glio 96.58 8.75
DM 96.30 10.33
CAD 97.29 12.45
CVA 103.25 9.49
AIDS 95.55 7.20
CJD 96.50 5.93
Autism 92.71 8.43
DS-50 91.81 4.12
Cerbral Palsy 95.33 11.78
CRF 97.38 10.76
Cirr/Hep Fail 97.77 13.24
Muc Angio 96.19 12.15
EMF 103.32 13.04
CCP 94.36 8.06
Exposure to EMF 103.28 11.47
F value 154.701
P value < 0.001
Table 20
RBC Hexokinase (ug glu phos/hr/mgpro)
Group Mean + SD
NO/BHCD 1.66 0.45
RHCD 5.46 2.83
LHCD 0.68 0.23
Schizo 7.69 3.40
Seizure 6.29 1.73
HD 9.30 3.98
AD 8.46 3.63
MS 8.56 4.75
SLE 8.02 3.01
NHL 7.41 4.22
Glio 7.82 3.51
DM 7.05 1.86
CAD 8.88 3.09
Group Mean + SD
CVA 7.87 2.72
AIDS 9.84 2.43
CJD 8.81 4.26
Autism 6.95 2.02
DS-50 8.68 2.60
Cerbral Palsy 7.92 3.32
CRF 7.75 3.08
Cirr/Hep Fail 8.99 3.27
Muc Angio 10.12 1.75
EMF 9.44 3.40
CCP 8.53 2.64
Exposure to EMF 7.58 3.09
F value 18.187
P value < 0.001
Table 21
ACOA (mg/dl)
Group Mean + SD
NO/BHCD 8.75 0.38
RHCD 2.51 0.36
LHCD 16.49 0.89
Schizo 2.51 0.57
Seizure 2.15 0.22
HD 1.95 0.06
AD 2.19 0.15
MS 2.03 0.09
SLE 2.54 0.38
NHL 2.30 0.26
Glio 2.34 0.43
DM 2.17 0.40
CAD 2.37 0.44
CVA 2.25 0.44
AIDS 2.11 0.19
CJD 2.10 0.27
Autism 2.42 0.41
DS-50 2.01 0.08
Cerbral Palsy 2.06 0.35
CRF 2.24 0.32
Cirr/Hep Fail 2.13 0.17
Muc Angio 2.51 0.42
EMF 2.19 0.19
CCP 2.04 0.10
Exposure to EMF 2.14 0.19
F value 1871.04
P value < 0.001
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Table 22
ACH (ug/ml)
Group Mean + SD
NO/BHCD 75.11 2.96
RHCD 38.57 7.03
LHCD 91.98 2.89
Schizo 48.52 6.28
Seizure 33.27 5.99
HD 35.02 5.85
AD 42.84 8.26
MS 39.99 12.61
SLE 49.30 7.26
NHL 50.58 3.82
Glio 42.51 11.58
DM 41.31 10.69
CAD 49.19 6.86
CVA 37.45 7.93
AIDS 38.40 7.74
CJD 34.97 4.24
Autism 50.61 6.32
DS-50 39.34 8.15
Cerbral Palsy 40.79 9.34
CRF 37.52 4.37
Cirr/Hep Fail 46.20 4.95
Muc Angio 45.51 7.56
EMF 42.48 8.62
CCP 37.95 8.82
Exposure to EMF 37.75 7.31
F value 116.901
P value < 0.001
Table 23
Glut (mg/dl)
Group Mean + SD
NO/BHCD 0.65 0.03
RHCD 3.19 0.32
LHCD 0.16 0.02
Schizo 3.41 0.41
Seizure 3.67 0.38
HD 3.14 0.32
AD 3.53 0.39
MS 3.58 0.36
SLE 3.37 0.38
NHL 3.48 0.46
Glio 3.28 0.39
DM 3.53 0.44
CAD 3.61 0.28
Group Mean + SD
CVA 3.31 0.43
AIDS 3.45 0.49
CJD 3.94 0.22
Autism 3.30 0.32
DS-50 3.30 0.48
Cerbral Palsy 3.24 0.34
CRF 3.26 0.43
Cirr/Hep Fail 3.25 0.40
Muc Angio 3.11 0.36
EMF 3.27 0.39
CCP 3.33 0.25
Exposure to EMF 3.47 0.37
F value 200.702
P value < 0.001
Table 24
Se. Amm.(ug/dl)
Group Mean + SD
NO/BHCD 50.60 1.42
RHCD 93.43 4.85
LHCD 23.92 3.38
Schizo 94.72 3.28
Seizure 95.61 7.88
HD 94.60 8.52
AD 95.37 4.66
MS 93.42 3.69
SLE 101.18 17.06
NHL 91.62 3.24
Glio 93.20 4.46
DM 93.38 7.76
CAD 93.93 4.86
CVA 103.18 27.27
AIDS 92.47 3.97
CJD 93.13 5.79
Autism 94.01 5.00
DS-50 98.81 15.65
Cerbral Palsy 92.09 3.21
CRF 98.76 11.12
Cirr/Hep Fail 94.77 2.86
Muc Angio 92.40 4.34
EMF 95.37 5.76
CCP 93.42 5.34
Exposure to EMF 102.62 26.54
F value 61.645
P value < 0.001
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Table 25
HMG Co A (HMG CoA/MEV)
Group Mean + SD
NO/BHCD 1.70 0.07
RHCD 1.16 0.10
LHCD 2.21 0.39
Schizo 1.11 0.08
Seizure 1.14 0.07
HD 1.08 0.13
AD 1.10 0.07
MS 1.13 0.08
SLE 1.14 0.07
NHL 1.12 0.10
Glio 1.10 0.09
DM 1.09 0.12
CAD 1.07 0.12
CVA 1.05 0.09
AIDS 1.08 0.11
CJD 1.09 0.12
Autism 1.12 0.06
DS-50 1.09 0.11
Cerbral Palsy 1.07 0.09
CRF 1.03 0.10
Cirr/Hep Fail 1.04 0.10
Muc Angio 1.12 0.08
EMF 1.08 0.08
CCP 1.01 0.09
Exposure to EMF 1.00 0.07
F value 159.963
P value < 0.001
Table 26
Bile Acid (mg/ml)
Group Mean + SD
NO/BHCD 79.99 3.36
RHCD 25.68 7.04
LHCD 140.40 10.32
Schizo 22.45 5.57
Seizure 22.98 5.19
HD 28.93 4.93
AD 26.26 7.34
MS 24.12 6.43
SLE 19.62 1.97
NHL 23.45 5.01
Glio 23.43 6.03
DM 22.77 4.94
CAD 24.55 6.26
Group Mean + SD
CVA 22.39 3.35
AIDS 23.28 5.81
CJD 21.26 4.81
Autism 23.16 5.78
DS-50 21.31 4.49
Cerbral Palsy 22.80 5.02
CRF 26.47 5.30
Cirr/Hep Fail 24.91 5.06
Muc Angio 24.37 4.38
EMF 25.17 3.80
CCP 23.87 4.00
Exposure to EMF 22.58 5.07
F value 635.306
P value < 0.001
DISCUSSION
There was increase in cytochrome F420 indicating archaeal 
growth. The archaea can synthesize and use cholesterol 
as a carbon and energy source[2,10]. The archaeal origin of 
the enzyme activities was indicated by antibiotic induced 
suppression. The study indicates the presence of actinide 
based archaea with an alternate actinide based enzymes 
or metalloenzymes in the system as indicated by rutile 
induced increase in enzyme activities[11]. The archaeal 
beta hydroxyl steroid dehydrogenase activity indicating 
digoxin synthesis[12]. The archaeal cholesterol oxidase 
activity was increased resulting in generation of pyruvate 
and hydrogen peroxide[10]. The pyruvate gets converted to 
glutamate and ammonia by the GABA shunt pathway. The 
pyruvate is converted to glutamate by serum glutamate 
pyruvate transaminase. The glutamate gets acted upon by 
glutamate dehydrogenase to generate alpha ketoglutarate 
and ammonia. Alanine is most commonly produced by the 
reductive amination of pyruvate via alanine transaminase. 
This reversible reaction involves the interconversion 
of alanine and pyruvate, coupled to the interconversion 
o f  a l p h a - k e t o g l u t a r a t e  ( 2 - o x o g l u t a r a t e )  a n d 
glutamate. Alanine can contribute to glycine. Glutamate 
is acted upon by Glutamic acid decarboxylase to generate 
GABA. GABA is converted to succinic semialdehyde by 
GABA transaminase. Succinic semialdehyde is converted 
to succinic acid by succinic semialdehyde dehydrogenase. 
Glycine combines with succinyl CoA to generate delta 
aminolevulinic acid catalysed by the enzyme ALA 
synthase. There was upregulated archaeal porphyrin 
synthesis in the patient population which was archaeal in 
origin as indicated by actinide catalysis of the reactions. 
The cholesterol oxidase pathway generated pyruvate 
which entered the GABA shunt pathway. This resulted in To be continued
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synthesis of succinate and glycine which are substrates 
for ALA synthase. The archaea can undergo magnetite 
and calcium carbonate mineralization and can exist as 
calcifi ed nanoforms[13]. 
The possibility of Warburg phenotype induced by 
actinide based primitive organism like archaea with a 
mevalonate pathway and cholesterol catabolism was 
considered in this paper. The Warburg phenotype results 
in inhibition of pyruvate dehydrogenase and the TCA 
cycle. The pyruvate enters the GABA shunt pathway 
where it is converted to succinyl CoA. The glycolytic 
pathway is upregulated and the glycolytic metabolite 
phosphoglycerate is converted to serine and glycine. 
Glycine and succinyl CoA are the substrates for ALA 
synthesis. The archaea induces the enzyme heme 
oxygenase. Heme oxygenase converts heme to bilirubin 
and biliverdin. This depletes heme from the system and 
results in upregulation of ALA synthase activity resulting 
in porphyria. Heme inhibits HIF alpha. The heme 
depletion results in upregulation of HIF alpha activity 
and further strengthening of the Warburg phenotype. 
The porphyrin self oxidation results in redox stress 
which activates HIF alpha and generates the Warburg 
phenotype. The Warburg phenotype results in channeling 
acetyl CoA for cholesterol synthesis as the TCA cycle and 
mitochondrial oxidative phosphorylation are blocked. The 
archaea uses cholesterol as an energy substrate. Porphyrin 
and ALA inhibits sodium potassium ATPase. This 
increases cholesterol synthesis by acting upon intracellular 
SREBP. The cholesterol is metabolized to pyruvate 
and then the GABA shunt pathway for ultimate use in 
porphyrin synthesis. The porphyrins can self organize and 
self replicate into macromolecular arrays. The porphyrin 
arrays behave like an autonomous organism and can have 
intramolecular electron transport generating ATP. The 
porphyrin macroarrays can store information and can have 
quantal perception. The porphyrin macroarrays serves the 
purpose of archaeal energetics and sensory perception. 
The Warburg phenotype is associated with malignancy, 
autoimmune disease and metabolic syndrome x.
The role of archaeal porphyrins in regulation of 
cell functions and neuroimmunoendocrine integration 
is discussed. Protoporphyrine binds to the peripheral 
benzodiazepine receptor regulating steroid and digoxin 
synthesis. Increased porphyrin metabolites can contribute 
to hyperdigoxinemia. Digoxin can modulate the 
neuroimmunoendocrine system. Porphyrins can combine 
with membranes modulating membrane function. 
Porphyrins can combine with proteins oxidizing their 
tyrosine, tryptophan, cysteine and histidine residues 
producing crosslinking and altering protein conformation 
and function. Porphyrins can complex with DNA and 
RNA modulating their function. Porphyrin interpolating 
with DNA can alter transcription and generate HERV 
expression. Heme deficiency can also result in disease 
states. Heme deficiency results in deficiency of heme 
enzymes. There is deficiency of cytochrome C oxidase 
and mitochondrial  dysfunction. The glutathione 
peroxidase is dysfunctional and the glutathione system of 
free radical scavenging does not function. The cytochrome 
P450 enzymes involved in steroid and bile acid synthesis 
have reduced activity leading to steroid- cortisol and sex 
hormones as well as bile acid defi ciency states. The heme 
defi ciency results in dysfunction of nitric oxide synthase, 
heme oxygenase and cysthathione beta synthase resulting 
in lack of gasotransmitters regulating the vascular system 
and NMDA receptor- NO, CO and H2S. Heme has got 
cytoprotective, neuroprotective, anti-inflammatory and 
antiproliferative effects. Heme is also involved in the 
stress response. Heme deficiency leads to metabolic 
syndrome, immune disease, degenerations and cancer.3-5
The porphyrins can undergo photo-oxidation and 
autooxidation generating free radicals. The archaeal 
porphyrins can produce free radical injury. Free radicals 
produce NFKB activation, open the mitochondrial PT 
pore resulting in cell death, produce oncogene activation, 
activate NMDA receptor and GAD enzyme regulating 
neurotransmission and generates the Warburg phenotypes 
activating glycolysis and inhibiting TCA cycle/oxphos. 
Porphyrins have been related to schizophrenia, metabolic 
syndrome x, malignancy, systemic lupus erythematosis, 
multiple sclerosis and Alzheimer ’s diseases. The 
porphyrins can complex and intercalate with the cell 
membrane producing sodium potassium ATPase inhibition 
adding on to digoxin mediated inhibition. Porphyrins 
can complex with proteins and nucleic acid producing 
biophoton emission. Porphyrins complexing with 
proteins can modulate protein structure and function. 
Porphyrins complexing with DNA and RNA can modulate 
transcription and translation. The porphyrin especially 
protoporphyrins can bind to peripheral benzodiazepine 
receptors in the mitochondria and modulate its function, 
mitochondrial cholesterol transport and steroidogenesis. 
Peripheral benzodiazepine receptor modulation by 
protoporphyrins can regulate cell death, cell proliferation, 
immunity and neural functions. The porphyrin photo-
oxidation generates free radicals which can modulate 
enzyme function. Redox stress modulated enzymes include 
pyruvate dehydrogenase, nitric oxide synthase, cystathione 
beta synthase and hemeoxygenase. Free radicals can 
modulate mitochondrial PT pore function. Free radicals 
can modulate cell membrane function and inhibit sodium 
potassium ATPase activity. Thus the porphyrins are 
key regulatory molecules modulating all aspects of cell 
function.3-5 There was an increase in free RNA indicating 
self replicating RNA viroids and free DNA indicating 
generation of viroid complementary DNA strands by 
archaeal reverse transcriptase activity. The actinides 
and porphyrins modulate RNA folding and catalyse its 
ribozymal action. Digoxin can cut and paste the viroidal 
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strands by modulating RNA splicing generating RNA 
viroidal diversity. The viroids are evolutionarily escaped 
archaeal group I introns which have retrotransposition 
and self splicing qualities. Archaeal pyruvate producing 
histone deacetylase inhibition and porphyrins intercalating 
with DNA can produce endogenous retroviral (HERV) 
reverse transcriptase and integrase expression. This can 
integrate the RNA viroidal complementary DNA into 
the noncoding region of eukaryotic non coding DNA 
using HERV integrase as has been described for borna 
and ebola viruses. The archaea and viroids can also 
induce cellular porphyrin synthesis. Bacterial and viral 
infections can precipitate porphyria. Thus porphyrins can 
regulate genomic function. The increased expression of 
HERV RNA can result in acquired immunodeficiency 
syndrome, autoimmune disease, neuronal degenerations, 
schizophrenia and malignancy[14,15].
The archaea and viroids can regulate the nervous system 
including the NMDA/GABA thalamocorticothalamic 
pathway mediating conscious perception. Porphyrin 
photo-oxidation can generate free radicals which can 
modulate NMDA transmission. Free radicals can increase 
NMDA transmission. Free radicals can induce GAD 
and increase GABA synthesis. ALA blocks GABA 
transmission and upregulates NMDA. Protoporphyrins 
bind to GABA receptor and promote GABA transmission. 
Thus porphyrins can modulate the thalamocorticothalamic 
pathway of conscious perception. The dipolar porphyrins, 
PAH and archaeal magnetite in the setting of digoxin 
induced sodium potassium ATPase inhibition can produce 
a pumped phonon system mediated frohlich model 
superconducting state inducing quantal perception with 
nanoarchaeal sensed gravity producing the orchestrated 
reduction of the quantal possibilities to the macrosopic 
world. ALA can produce sodium potassium ATPase 
inhibition resulting in a pumped phonon system mediated 
quantal state involving dipolar porphyrins. Porphyrin 
molecules have a wave particle existence and can bridge 
the dividing line between quantal state and particulate 
state. Thus the porphyrins can mediate conscious and 
quantal perception. Porphyrins binding to proteins, nucleic 
acids and cell membranes can produce biophoton emission. 
Porphyrins by autooxidation can generate biophotons 
and are involved in quantal perception. Biophotons can 
mediate quantal perception. Cellular porphyrins photo-
oxidation are involved in sensing of earth magnetic fi elds 
and low level biomagnetic fields. Thus prophyrins can 
mediate extrasensory perception. The porphyrins can 
modulate hemispheric dominance. There is increased 
porphyrin synthesis and RHCD and decreased porphyrin 
synthesis in LHCD. The increase in archaeal porphyrins 
can contribute to the pathogenesis of schizophrenia 
and autism. Porphyria can lead to psychiatric disorders 
and seizures. Altered porphyrin metabolism has been 
described in autism. Porphyrins by modulating conscious 
and quantal perception is involved in the pathogenesis of 
schizophrenia and autism. Protoporphyrins block acetyl 
choline transmission producing a vagal neuropathy with 
sympathetic overactivity. Vagal neuropathy results in 
immune activation, vasospasam and vascular disease. A 
vagal neuropathy underlines neoplastic and autoimmune 
processes as well as metabolic syndrome x. Porphyrin 
induced increased NMDA transmission and free radical 
injury can contribute to neuronal degeneration. Free 
radicals can produce mitochondrial PT pore dysfunction. 
This can lead to cytoC leak and activation of the caspase 
cascade leading to apoptosis and cell death. Altered 
porphyrin metabolism has been described in Alzheimer’s 
disease. The increased porphyrin photo-oxidation 
generated free radicals mediated NMDA transmission can 
also contribute to epileptogenesis. The protoporphyrins 
binding to mitochondrial benzodiazepine receptors can 
regulate brain function and cell death[3,4,16].
The porphyrin photo-oxidation can generate free 
radicals which can activate NFKB. This can produce 
immune activation and cytokine mediated injury. The 
increase in archaeal porphyrins can lead to autoimmune 
disease like SLE and MS. A hereditary form of MS and 
SLE related to altered porphyrin metabolism has been 
described. The protoporphyrins binding to mitochondrial 
benzodiazepine receptors can modulate immune function. 
Porphyrins can combine with proteins oxidizing their 
tyrosine, tryptophan, cysteine and histidine residues 
producing crosslinking and altering protein conformation 
and function. Porphyrins can complex with DNA and 
RNA modulating their structure. Porphyrin complexed 
with proteins and nucleic acids are antigenic and can 
lead onto autoimmune disease[3,4]. The porphyrin photo-
oxidation mediated free radical injury can lead to insulin 
resistance and atherogenesis. Thus archaeal porphyrins 
can contribute to metabolic syndrome x. Glucose has 
got a negative effect upon ALA synthase activity. 
Therefore hyperglycemia may be reactive protective 
mechanism to increased archaeal porphyrin synthesis. The 
protoporphyrins binding to mitochondrial benzodiazepine 
receptors can modulate mitochondrial steroidogenesis 
and metabolism. Altered porphyrin metabolism has been 
described in the metabolic syndrome x. Porphyrias can 
lead onto vascular thrombosis[3,4]. The porphyrin photo-
oxidation can generate free radicals inducing HIF alpha 
and producing oncogene activation. Heme defi ciency can 
lead to activation of HIF alpha and oncogenesis. This 
can lead to oncogenesis. Hepatic porphyrias induced 
hepatocellular carcinoma. The protoporphyrins binding 
to mitochondrial benzodiazepine receptors can regulate 
cell proliferation[3,4]. The porphyrin can combine with 
prion proteins modulating their conformation. This leads 
to abnormal prion protein conformation and degradation. 
Archaeal porphyrins can contribute to prion disease. The 
porphyrins can intercalate with DNA producing HERV 
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expression. The HERV particles generated can contribute 
to the retroviral state. The porphyrins in the blood can 
combine with bacteria and viruses and the photo-oxidation 
generated free radicals can kill them. The archaeal 
porphyrins can modulate bacterial and viral infections. 
The archaeal porphyrins are regulatory molecules keeping 
other prokaryotes and viruses on check[3,4]. Thus the 
archaeal porphyrins can contribute to the pathogenesis of 
metabolic syndrome x, malignancy, psychiatric disorders, 
autoimmune disease, AIDS, prion disease, neuronal 
degeneration and epileptogenesis. Archaeal porphyrin 
synthesis is crucial in the pathogenesis of these disorders. 
Porphyrins may serve as regulatory molecules modulating 
immune, neural, endocrine, metabolic and genetic 
systems. The porphyrins photo-oxidation generated 
free radicals can produce immune activation, produce 
cell death, activate cell proliferation, produce insulin 
resistance and modulate conscious/quantal perception. The 
archaeal porphyrins functions as key regulatory molecules 
with mitochondrial benzodiazepine receptors playing an 
important role[3,4].
The metal actinides provide radiolytic energy, catalysis 
for oligomer formation and provide a coordinating ion 
for metalloenzymes all important in abiogenesis[6]. The 
metal actinide surfaces would by surface metabolism 
generate porphyrins from simple compounds like 
succinic acid and glycine. Porphyrins can exist as wave 
forms and particulate forms and can bridge the dividing 
line between the quantal world and particulate world. 
Porphyrin molecules can self organize into organisms 
with energy transduction, ATP synthesis and information 
storage with replicating capacity. A self replicating 
porphyrin microorganism may have played a role in the 
origin of life. Porphyrins can form templates on which 
macromolecules like polysaccharides, protein and nucleic 
acids can form. The macromolecules generated on 
actinidic porphyrins templates would have contributed to 
the actinidic nanoarchaea and the original organisms on 
earth. The data supports the persistence of an actinidic 
archaeal shadow biosphere which throws light on the 
actinide based origin of life and porphyrins as the premier 
prebiotic molecule[17,18].
Porphyrins play an important role in the genesis of the 
biological universe. The porphyrin macroarrays can form 
in the interstellar space on its own as porphyrins can exist 
both as particles and waves. Porphyrins form the bridging 
connection between the quantal world and the particulate 
world. The self generated porphyrins from the quantal 
foam can self organize to form macroarrays, can store 
information and self replicate. This can be called as an 
abiotic porphyrin organism. The porphyrin template would 
have generated nucleic acids, proteins, polysaccarides 
and isoprenoids. This would have generated actinidic 
nanoarchaea in the interstellar space. The porphyrins 
have magnetic properties and the interstellar porphyrin 
organism can contribute to the interstellar grains and 
interstellar magnetic fields. The cosmic dust grains of 
porphyrin macroarrays/nanoarchaeal organism occupy 
the intergalactic space and are thought to be formed 
of magnetotactic bacteria identified according to their 
spectral signatures. According to the Hoyle’s hypothesis, 
the cosmic dust magnetotactic porphyrin macroarrays/
nanoarchaeal organism plays a role in the formation of 
the intergalactic magnetic field. A magnetic field equal 
in strength to about one millionth part of the magnetic 
fi eld of earth exists throughout much of our galaxy. The 
magnetic files can be used to trace the spiral arms of 
the galaxy following a pattern of fi eld lines that connect 
young stars and dust in which new stars are formed at 
a rapid rate. Studies have shown that a fraction of the 
dust particles have elongated shape similar to bacilli and 
they are systematically lined up in our galaxy. Moreover 
the direction of alignment is such that the long axes of 
the dust tend to be at right angles to the direction of the 
galactic magnetic field at every point. Magnetotactic 
porphyrin macroarrays/nanoarchaeal organism have 
the property to affect the degree of alignment that is 
observed. The fact that the magnetotactic porphyrin 
macroarrays/nanoarchaeal organisms appear to be 
connected to the magnetic fi eld lines that thread through 
the spiral arms of the galaxy connecting one region of 
star formation to another support a role for them in star 
formation and in the mass distribution and rotation of 
stars. The nutrient supply for a population of interstellar 
porphyrin macroarrays/nanoarchaeal organisms comes 
from mass fl ows out of supernovas populating the galaxy. 
Giants arising in the evolution of such stars experience 
a phenomenon in which material containing nitrogen, 
carbon monoxide, hydrogen, helium, water and trace 
elements essential for life fl ows continuously outward into 
space. The interstellar organisms need liquid water. Water 
exists only as vapour or solid in the interstellar space 
and only through star formation leading to associated 
planets and cometary bodies can there be access to liquid 
water. To control conditions leading to star formation is 
of paramount importance in cosmic biology. The rate of 
star formation is controlled by two factors: Too high a 
rate of star formation produces a destructive effect of UV 
radiation and destroys cosmic biology. Star formation as 
stated before produces water crucial for organism growth. 
Cosmic biology of magnetotactic organisms and star 
formation are thus closely interlinked. Systems like solar 
systems do not arise in random condensation of blobs 
of interstellar gas. Only by a rigorous control of rotation 
of various parts of the system would galaxies and solar 
system evolved. The key to maintaining control over 
rotation seems to lie in the intergalactic magnetic field 
as indeed the whole phenomena of star formation. The 
intergalactic magnetic fi elds owes its origin to the lining 
up of magnetotactic porphyrin macroarrays/nanoarchaeal 
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organisms and the cosmic biology of interstellar 
organisms can prosper only by maintaining a fi rm grip on 
the interstellar magnetic fi eld and hence on the rate of star 
formation and type of star system produced. This point 
to a cosmic intelligence or brain capable of computation, 
analysis and exploration of the universe at large of 
magnetotactic porphyrin macroarrays/nanoarchaeal 
organism networks. The origin of life on earth according 
to the Hoyle’s hypothesis would be by seeding of 
porphyrin macroarrays/nanoarchaeal organism from the 
outer intergalactic space. The porphyrin organism can 
also be generated on actinidic surfaces in earth. Comets 
carrying porphyrin organisms would have interacted 
with the earth. A thin skin of graphitized material 
around a single porphyrin macroarrays/nanoarchaeal 
organism or clumps of organism can shield the interior 
from destruction by UV light. The sudden surge and 
diversifi cation of species of plants and animals and their 
equally sudden extinction has seen from fossil records 
point to sporadic evolution produced by induction of fresh 
cometary genes with the arrival of each major new crop 
of comets. The porphyrin macroarrays organism can have 
a wave particle existence and bridge the world of bosons 
and fermions. The porphyrin macroarrays/nanoarchaeal 
organism can form biofilms and the porphyrin organism 
can form a molecular quantum computing cloud in the 
biofi lm which forms an interstellar intelligence regulating 
the formation of star systems and galaxies. The porphyrin 
macroarrays/nanoarchaeal organism quantal computing 
cloud can bridge the wave particle world functioning as 
the anthropic observer sensing gravity which orchestrates 
the reduction of the quantal world of possibilities in to 
the macroscopic world. The actinide based porphyrin 
macroarrays/nanoarchaeal organism regulates the human 
system and biological universe[19-21]. 
Porphyrins also have evolutionary significance since 
porphyria is related to Scythian races and contributes to 
the behavioural and intellectual characteristics of this 
group of population. Porphyrins can intercalate into 
DNA and produce HERV expression. HERV RNA can 
get converted to DNA by reverse transcriptase which 
can get integrated into DNA by integrase. This tends to 
increase the length of the non coding region of the DNA. 
The increase in non coding region of the DNA is involved 
in primate and human evolution. Thus, increased rates 
of porphyrin synthesis would correlate with increase 
in non coding DNA length. The alteration in the length 
of the non coding region of the DNA contributes to the 
dynamic nature of the genome. Thus genetic and acquired 
porphyrias can lead to alteration in the non coding region 
of the genome. The alteration of the length of the non 
coding region of the DNA contributes to the racial and 
individual differences in populations. An increased length 
of non coding region as well as increased porphyrin 
synthesis leads to increased cognitive and creative 
neuronal function. Porphyrins are involved in quantal 
perception and regulation of the thalamocorticothalamic 
pathway of conscious perception. Thus genetic and 
acquired porphyrias contribute to higher cognitive and 
creative capacity of certain races. Porphyrias are common 
among Eurasian Scythian races who have assumed 
leadership roles in communities and groups. Porphyrins 
have contributed to human and primate evolution[3,4].
The dipolar porphyrins, PAH and archaeal magnetite in 
the setting of digoxin induced sodium potassium ATPase 
inhibition can produce a pumped phonon system mediated 
frohlich model superconducting state inducing quantal 
perception with nanoarchaeal sensed gravity producing 
the orchestrated reduction of the quantal possibilities 
to the macrosopic world. ALA can produce sodium 
potassium ATPase inhibition resulting in a pumped 
phonon system mediated quantal state involving dipolar 
porphyrins. Porphyrins by autooxidation can generate 
biophotons and are involved in quantal perception. 
Biophotons can mediate quantal perception. Cellular 
porphyrins photo-oxidation are involved in sensing of 
earth magnetic fields and low level biomagnetic fields. 
Porphyrins can thus contribute to quantal perception. 
Low level electromagnetic fields and light can induce 
porphyrin synthesis. Low level EMF can produce 
ferrochelatase inhibition as well as heme oxygenase 
induction contributing to heme depletion, ALA synthase 
induction and increased porphyrin synthesis. Light 
also induces ALA synthase and porphyrin synthesis. 
The increased porphyrin synthesized can contribute to 
increased quantal perception and can modulate conscious 
perception. The porphyrin induced biophotons and quantal 
fi elds can modulate the source from which low level EMF 
and photic fields were generated. Thus the porphyrin 
generated by extraneous low level EMF and photic fi elds 
can interact with the source of low level EMF and photic 
fi elds modulating it. Thus porphyrins can serve as a bridge 
between the human brain and the source of low level EMF 
and photic fi elds. This serves as a mode of communication 
between the human brain and EMF storage devices like 
internet. The porphyrins can also serve as the source of 
communication with the environment. Environmental 
EMF and chemicals produce heme oxygenase induction 
and heme depletion increasing porphyrin synthesis, 
quantal perception and two-way communication. 
Thus induction of porphyrin synthesis can serve as a 
mechanism of communication between human brain and 
the environment by extrasensory perception. 
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